Ascites Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

Ascites Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

“Delveinsight Business Research LLP”
DelveInsight’s “Ascites Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Ascites, historical and forecasted epidemiology as well as the Ascites market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Ascites are defined as an accumulation of more than 25 mL of fluid in the peritoneal cavity. Cirrhosis of the liver is the most common cause of ascites, but other conditions such as heart failure, kidney failure, infection, or cancer can also cause the disease. Ascites are caused by a combination of elevated pressure in the veins running through the liver (portal hypertension) and a decrease in liver function caused by scarring of the liver, i.e., cirrhosis.

Ascites related to portal hypertension (cirrhosis, congestive heart failure, Budd-Chiari) are generally greater than 1.1., and ascites caused by other reasons (malignant, pancreatitis) are lower than 1.1.

Get FREE sample copy at: 
https://www.delveinsight.com/sample-request/ascites-market

The Ascites market report also covers emerging drugs, current treatment practices, Ascites market share of the individual therapies, current and forecasted Ascites Market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Ascites treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market. 

Ascites Market

Ascites Market Key Facts

  • As per the study conducted by Carrier et al. (2014), in France, around 20% of the cases of ascites are not linked to liver cirrhosis.

  • In the United States, in ~85% of patients with ascites, cirrhosis is the cause, but 15% have a non-hepatic cause of fluid accumulation. Around 5% of patients had “mixed” ascites or had two or more causes for the ascites, typically cirrhosis plus another reason (Iris et al., 2018).

  • As per the study conducted by Bruce et al. (2009), approximately 50% of patients with “compensated” cirrhosis, i.e., without having developed one of these complications, develop ascites during 10 years of observation.

  • The study conducted by Peltekian et al. (2019) suggests that males are more likely to suffer from Ascites as compared to females.

Key Benefits of Ascites Market Report

  • Ascites market report provides an in-depth analysis of Ascites Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.

  • The Ascites market report will help in developing business strategies by understanding the Ascites Market trends & developments, key players, and future market competition that will shape and drive the Ascites market in the upcoming years.

  • The Ascites market report covers Ascites current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.

  • The report provides a detailed assessment of the Ascites market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

Ascites Market

Ascites Market Size is expected to increase during the study period owing to the increasing incidence of Ascites and expected approval of emerging therapies.

The Ascites market outlook section of the report helps to build a detailed comprehension of the historic, current and forecasted Ascites market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Ascites market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

Ascites Epidemiology

The Ascites epidemiology section covers insights about the historical and current Ascites patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Ascites Drugs Uptake and Key Market Players

The Ascites Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Ascites market or expected to get launched in the market during the study period. The analysis covers Ascites market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Some of the key companies in the Ascites market include:
BioVie
Grifols S.A.
Noorik Biopharmaceuticals
Clover Biopharmaceuticals
And many others.

Ascites therapies covered in the report include:
BIV201
N-003
SCB-313
Albutein 20% Injectable Solution
And many more.

Table of Content

1. Key Insights

2. Executive Summary 

3. Ascites Competitive Intelligence Analysis

4. Ascites Market Overview at a Glance

5. Ascites Disease Background and Overview

6. Ascites Patient Journey

7. Ascites Epidemiology and Patient Population

8. Ascites Treatment Algorithm, Current Treatment, and Medical Practices

9. Ascites Unmet Needs

10. Key Endpoints of Ascites Treatment

11. Ascites Marketed Products

12. Ascites Emerging Therapies

13. Ascites Seven Major Market Analysis

14. Attribute Analysis

15. Ascites Market Outlook (7 major markets)

16. Ascites Access and Reimbursement Overview

17. KOL Views on the Ascites Market.

18. Ascites Market Drivers

19. Ascites Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Related Reports
Ascites Pipeline Insights
Ascites Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Ascites market.

Latest BioPharma Blogs – Hallux Valgus Therapeutics Market

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd. 2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/